RIO DE JANEIRO, BRAZIL - Pharmaceutical sector specialists explained why in 2021, the country broke the decade record in the number of trials and described the multiple benefits that this generates.
Some improvements introduced by the National Administration of Medicines, Food, and Medical Technology (ANMAT) added to the prestige of the Argentine medical community at the international level and promoted a significant increase in the country's overall participation in clinical trials during 2021.
Clinical trials are . . .
To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed? Login Here